- Investing Ideas
- /
- U.S. High Growth Potential Companies
U.S. High Growth Potential Companies
Results
1520
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
1,520 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
FTAI | US$128.71 | -0.5% | 121.2% | US$13.3b | US$185.51 | PS7.6x | E46.0% | 0.9% | Capital Goods | ||
PHAT | US$5.52 | -2.6% | -48.4% | US$393.9m | US$24.63 | PS14.4x | E51.3% | n/a | Pharmaceuticals & Biotech | ||
RCAT | US$6.20 | -20.1% | 731.1% | US$497.0m | US$13.50 | PS30.2x | E106.1% | n/a | Tech | ||
SEI | US$34.15 | -5.0% | 301.3% | US$2.2b | US$46.50 | PE87.9x | E82.0% | 1.4% | Energy | ||
BHLB | US$28.49 | 1.5% | 32.6% | US$1.3b | US$34.55 | PB1.1x | E84.9% | 2.5% | Banks | ||
TMDX | US$76.32 | 6.1% | -7.7% | US$2.4b | US$102.86 | PE72.4x | E27.1% | n/a | Healthcare | ||
AUB | US$35.67 | 1.2% | 7.6% | US$3.2b | US$46.60 | PB1x | E52.7% | 3.8% | Banks | ||
SLAB | US$140.30 | -9.7% | -0.9% | US$4.6b | US$144.89 | PS7.8x | E107.2% | n/a | Semiconductors | ||
ARCT | US$16.79 | -5.5% | -57.7% | US$454.8m | US$76.32 | PS2.8x | E58.2% | n/a | Pharmaceuticals & Biotech | ||
APLS | US$25.15 | -8.6% | -60.6% | US$3.1b | US$45.80 | PS4x | E65.4% | n/a | Pharmaceuticals & Biotech | ||
EVR | US$241.80 | -3.3% | 29.8% | US$9.9b | US$326.71 | PE25x | E22.3% | 1.3% | Diversified Financials | ||
PSTG | US$52.47 | -19.4% | -5.2% | US$17.4b | US$71.52 | PE160.4x | E32.1% | n/a | Tech | ||
NET | US$145.30 | -4.4% | 45.4% | US$48.5b | US$144.02 | PS30x | E32.1% | n/a | Software | ||
RADA | US$9.87 | -2.4% | 5.0% | US$490.9m | US$14.00 | PE85x | E83.7% | n/a | Capital Goods | ||
LMB | US$83.00 | 3.6% | 62.8% | US$885.7m | US$115.33 | PE35.6x | E21.0% | n/a | Capital Goods | ||
BWB | US$14.50 | 3.0% | 23.4% | US$393.2m | US$17.50 | PB1x | E20.1% | n/a | Banks | ||
BZ | US$16.00 | 0% | -2.1% | US$6.8b | US$16.95 | PE34.6x | E25.3% | n/a | Media | ||
MRM | US$0.69 | -18.6% | -88.4% | US$5.3m | US$5.01 | PS0.1x | E122.9% | n/a | Consumer Services | ||
ESE | US$164.88 | 1.7% | 62.8% | US$4.1b | US$166.75 | PE38.6x | E20.4% | 0.2% | Capital Goods | ||
HRI | US$143.48 | -12.5% | -12.1% | US$4.1b | US$228.89 | PE19.4x | E32.3% | 2.0% | Capital Goods | ||
DASH | US$198.44 | -0.8% | 55.7% | US$82.3b | US$218.78 | PE677.8x | E37.7% | n/a | Consumer Services | ||
SHLS | US$3.03 | -33.0% | -77.3% | US$582.0m | US$6.61 | PE21x | E23.8% | n/a | Capital Goods | ||
PEN | US$285.44 | -2.1% | 20.6% | US$10.8b | US$309.75 | PE784.6x | E32.6% | n/a | Healthcare | ||
ADMA | US$16.39 | 3.5% | 196.9% | US$3.6b | US$24.27 | PE56.9x | E26.7% | n/a | Pharmaceuticals & Biotech |